BMGF – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement

• Post author:GHIAA Admin
• Post published:April 25, 2022
• Post category:

Continue ReadingBMGF – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement

BMGF – Arsanis RSV Monoclonal Antibodies Funding Agreement

• Post author:GHIAA Admin
• Post published:April 25, 2022
• Post category:

Continue ReadingBMGF – Arsanis RSV Monoclonal Antibodies Funding Agreement

CEPI – Dynavax, COVID-19 Material Reservation Agreement

• Post author:GHIAA Admin
• Post published:January 28, 2022
• Post category:

Continue ReadingCEPI – Dynavax, COVID-19 Material Reservation Agreement

CEPI – Valneva, Chikungunya Vaccine Funding Agreement

• Post author:GHIAA Admin
• Post published:August 23, 2021
• Post category:

Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement

BMGF – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue ReadingBMGF – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments

BMGF – CureVac, Global Access Commitments Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue ReadingBMGF – CureVac, Global Access Commitments Agreement

CEPI – CureVac, Framework Partnering Agreement

• Post author:GHIAA Editor
• Post published:June 30, 2021
• Post category:

Continue ReadingCEPI – CureVac, Framework Partnering Agreement

CEPI – Novavax, COVID-19 Vaccine Funding Agreement

• Post author:GHIAA Editor
• Post published:May 14, 2021
• Post category:

Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement

Gates Foundation Sample Grant Terms & Conditions

• Post author:Loren
• Post published:May 30, 2020
• Post category:

Continue ReadingGates Foundation Sample Grant Terms & Conditions